BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180428
DTEND;VALUE=DATE:20180908
DTSTAMP:20260825T164748
CREATED:20180428T131558Z
LAST-MODIFIED:20180428T131558Z
UID:19962-1524873600-1536364799@ces.b2sg.org
SUMMARY:Postdoc Research Associate
DESCRIPTION:This position will employ a wide range of experimental systems and interdisciplinary approaches and provide broad training in 3 areas: a.) control of cell cycle and tumor suppression by the ubiquitin pathway\, b.) tumor metabolism\, and c.) epigenetic control during tumorigenesis and innate immunity with an emphasis on the regulation of DNA de/methylation. The incumbent will be employed to carry out advanced independent and/or directed research to achieve the objectives of the research project. The principal investigator will establish the professional objectives and performance standards for the incumbent and will make annual evaluations. \n\n\n\n\nMinimum Qualifications: \nThis position requires knowledge of the fields\, processes and disciplines of cell biology and cancer metabolism. The position will involve organizing and implementing research plans\, the development of methods of research\, testing and data collection\, analysis and evaluation\, and writing reports containing descriptive\, analytical and evaluative content. The duties require discretion and judgement in carrying out research activities within the predetermined research scope and methodology. A PhD degree in the appropriate biomedical science or related field or discipline\, or the recognized terminal degree\, is required.
URL:https://ces.b2sg.org/event/unc-28apr18/
LOCATION:University of North Carolina – UNC-Chapel Hill\, Chapel Hill\, NC\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/U_North_Carolina-2.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180624
DTEND;VALUE=DATE:20180726
DTSTAMP:20260825T164748
CREATED:20180624T084841Z
LAST-MODIFIED:20180624T085018Z
UID:20401-1529798400-1532563199@ces.b2sg.org
SUMMARY:Associate Scientist
DESCRIPTION:Pfizer’s Oncology Research Unit (ORU) in La Jolla\, California is seeking an Associate Scientist focused on translating basic discoveries in the field of cancer epigenetics into novel therapeutics. \nOur ideal candidate will work within in a collaborative team environment to perform laboratory-based research. The candidate employ genetic and pharmacological to discover and confirm candidates for novel cancer therapeutics. As a member of the group\, you will also be involved in mechanism-of-action studies\, the interpretation and presentation of data\, and will function as an integral member of the team to advance new targets. The successful candidate will have experience in state-of-the-art techniques in epigenomic profiling (ATAC-seq\, ChIP-seq) as well as a basic understanding of epigenetic regulation in the tumor microenvironment. \nROLE RESPONSIBILITIES \nWill report into a team leader within the Epigenetics group. Expected to collaborate with scientists within the Oncology Research Division and across partner lines including Chemistry\, Global Business Technology\, Pharmacokinetics\, Dynamics &Metabolism\, Drug Safety R&D\, Pharmaceutical Science\, and compound management. \nPrimary Duties: \nWork as part of project teams to design\, execute\, analyze/interpret\, and refine experiments ranging from: biochemical and molecular assays\, target modulation\, biomarker assay development. \nDepending upon the stage of project\, specific duties to include: \n\nApplication of genetic and pharmacologic approaches to modulate drug targets in vitro\, and assess functional impact on cancer initiation and progression. This will include functional genomics techniques\, viral vector delivery\, transfection\, antibodies\, small molecules and other pharmacologic approaches to modulate targets in vitro.\nDevelop\, optimize\, and implement assays that constitute the compound screening funnel.\nGenerate engineered cell lines for primary and secondary pharmacology.\nExecute secondary cell-based assays across various technology platforms – qPCR\, ChIP\, RNA-seq\, ATAC-seq\, FACS\, immunofluorescence\, western blotting\, ELISA\, high content screening\, etc.\nApply complex in vitro assays for target validation and secondary pharmacology: spheroid models\, colony forming assays\, 3D co-culture systems.\nCollaborate with in vivo pharmacology group for efficacy testing\, PK/PD and pre-clinical PoC experiments.\nIn addition to efficacy testing\, carry out supporting assays (ELISA\, western blot\, gene expression analysis of tissue lysates) to assess target modulation levels and downstream effects.\nUse electronic data capture/analysis tools such as Excel\, GraphPad\, Biobook\, Spotfire and PowerPoint for experimental documentation and data analysis/presentations.\nPresent research results and methodologies at weekly meetings with immediate supervisor\, at Epigenetic team meetings\, and with members of the oncology research unit as appropriate (example: project team meetings).\nContribute to building a culture that embraces scientific excellence\, urgency\, continuous learning and improvement\, increasing technical skill base and cancer biology expertise; take a proactive role in personal growth and scientific development.\n\nBASIC QUALIFICATIONS \n\nB.S. in Cell Biology\, Molecular Biology (or a comparable biological science) with 0-3 years of related work experience.\nHands on experience with cell-based assays to monitor and analyze effects of target modulation (ELISA\, ICW\, FRET\, Luminescence based assays).\nExperience in functional genomics techniques (CRISPR\, RNAi) for target assessment and generation of cell lines.\nExperience in molecular biology techniques for analysis of chromatin structure/function (ATAC-seq\, ChIP-seq)\, gene expression\, and protein expression\nMust be able to work in a team environment\, have excellent communication skills and be able to present data at project team meetings.\nAbility to master new concepts and techniques quickly.\nStrong attention to detail and organizational skills to manage projects in parallel
URL:https://ces.b2sg.org/event/pfizer-24jun18/
LOCATION:Pfizer – La Jolla\, CA\, 10350 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/pfizer_new_logo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180627
DTEND;VALUE=DATE:20180729
DTSTAMP:20260825T164748
CREATED:20180627T162152Z
LAST-MODIFIED:20180627T163128Z
UID:20406-1530057600-1532822399@ces.b2sg.org
SUMMARY:Associate or Full Professor
DESCRIPTION:RPCI is soliciting applications to strengthen its NCI’s Cancer Center Support Grant Program in Cell Stress and Biophysical Therapies (CSBT). Prospective candidates must have a strong record of independent\, extramurally funded program of cancer-related research that will complement the ongoing CSBT Program. Prospective candidates are expected to have active programs in the following areas: molecular (genetic\, epigenetic and biochemical)\, cellular and systemic mechanisms of organismal response to stresses\, pathologies associated with cancer treatment and aging\, as well as development of new original cancer treatment approaches. Proven ability to acquire extramural funding\, along with a strong publication record and other indications of academic activity and visibility are required.  \nRPCI is the world’s oldest cancer center established in 1898\, which is known for numerous basic science and translational discoveries in oncology. RPCI is a NCI-recognized Comprehensive Cancer Center that runs multidisciplinary research combining\, under the umbrella of its CCS Grant\, multiple Programs aimed at understanding\, preventing and curing cancer. It has state-of-the-art research infrastructure enabling all aspects of modern biomedical research – from discovery work towards clinical validation – and provides a highly stimulating academic and clinical environment.
URL:https://ces.b2sg.org/event/rpci-27jun18/
LOCATION:Roswell Park Cancer Institute\, 665 Elm St\, Buffalo\, NY\, 14203\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/06/roswell-park-cancer-institute_416x416.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180630
DTEND;VALUE=DATE:20180802
DTSTAMP:20260825T164748
CREATED:20180630T203206Z
LAST-MODIFIED:20180630T203651Z
UID:20416-1530316800-1533167999@ces.b2sg.org
SUMMARY:Postdoctoral Fellow - Cancer Biology (Myeloma)
DESCRIPTION:Translational Development at Celgene is pleased to present a growth opportunity for outstanding post-doctoral fellows with a passion for hematology-oncology research and clinical development towards improved outcomes in myeloma patient healthcare. The multiple myeloma Translational Development team currently employs state of the art platforms and analytics to address the most important questions that will drive the current and next generation of therapeutic development for myeloma patients. \nThe successful candidate will become part of diverse team with a unified bench-to-bedside vision in precision healthcare and diagnostic approaches to biomarker utilization. The overarching goal of the successful candidate will be to provide\, through passionate research efforts\, clinically implementable information to better understand how patient characteristics\, malignancy biology and immune context features align to define patient outcomes from treatment with portfolio therapeutics and enable rationale combo design. This fellowship will work alongside top shelf scientists with deep knowledge of myeloma disease biology and further expertise including genomic definition of risk and outcomes\, immune characterization\, definition of response and tumoral evolution using single cell platforms and lab-based screens to better understand mechanistics of clinically-observed phenomenon. \nSkills/Knowledge Required: \n\nPhD in cancer biology\, genetics\, epigenetics\nStrong background in disease or mechanism based studies using modern experimental and computational methods is required.\nKnowledge of myeloma is desirable but not required.\nExperience in heme malignancy related areas\nWhile understanding of epigenetics and epigenetic experimental approaches are not essential\, it is highly desirable.\nPrior experience in molecular\, cellular\, functional and computational methods\nAbility to formulate experimental ideas\nDemonstrated writing and commutation skills\nAbility work in a collaborative team science environment
URL:https://ces.b2sg.org/event/celgene-30jun18/
LOCATION:Celgene\, 86 Morris Ave\, Summit\, NJ\, 07901\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/celgene-1-e1503843775806.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180711
DTEND;VALUE=DATE:20180813
DTSTAMP:20260825T164748
CREATED:20180711T105533Z
LAST-MODIFIED:20180711T105533Z
UID:20419-1531267200-1534118399@ces.b2sg.org
SUMMARY:Postdoctoral Fellowship - Genetics\, Epigenetic Regulation
DESCRIPTION:Positions of two postdoctoral scientists are open now in the Chen laboratory ( https://www.cityofhope.org/faculty/jianjun-chen ). Our group is interested in discovering novel genetic and epigenetic regulations and deciphering their underlying molecular mechanisms in normal developmental processes (e.g.\, hematopoiesis) and tumorigenesis (e.g.\, leukemogenesis). We cover research areas with relevance to Hematology\, Immunology\, and Cancer Biology\, with an emphasis on RNA epigenetics (mainly focusing on the N 6 methyladenosine (m 6 A) modification) and DNA epigenetics (mainly focusing on the TET1/2/3-mediated DNA demethylation) associated basic and translational research. Our research involves experiments with primary human cancer cells\, cancer and stem cell transplantation models\, mouse genetics\, classic molecular\, biochemistry and cell biology\, functional genomics\, signal transduction\, and large-scale data analysis and computational biology.  \nMinimum Education and Skills Required for Consideration:\nThe candidates for the Postdoctoral scientist positions should have a Ph.D. and/or M.D. degree(s)\, and a solid background in biochemistry\, mouse model studies\, hematology\, epigenetics\, immunology\, pathology\, and/or stem cell research is preferred for. The candidates should not have more than three years of postdoc training experience. The candidates should be highly motivated individuals with the ability to work in a team environment and with good oral and written communication skills in English.  \nApplication:\nPlease apply to this job posting. Additionally\, your application\, including CV\, brief motivation statement\, and contact information of three scientific mentors (references)\, should be saved as a single PDF. The PDF file can be sent to Dr. Jianjun Chen ( jianchen@coh.org ) directly. 
URL:https://ces.b2sg.org/event/hope-11jul18/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180712
DTEND;VALUE=DATE:20180814
DTSTAMP:20260825T164748
CREATED:20180712T071500Z
LAST-MODIFIED:20180712T071500Z
UID:20422-1531353600-1534204799@ces.b2sg.org
SUMMARY:Postdoctoral Scientist - Cancer Biology
DESCRIPTION:The George Washington University invites applications from outstanding scientists interested in contributing to the research program of the recently established George GWCC. Areas of particular interest are cancer epigenetics\, cancer immunology and immunotherapy\, and viral/microbial oncology. Examples include gene regulation\, signal transduction\, cancer genetics\, and functional genomics and proteomics. \nThe GWCC at George Washington University has an immediate opening for a Post-Doctoral Scientist position in the laboratory of Dr. Mamta Gupta to study role of epigenetic marks\, including histone modifications and long non-coding RNAs in the pathogenesis of lymphoma. \nThe Post-doctoral Scientist utilizes several techniques including DNA methylation and histone marks\, RNA-IP\, ChIP assay\, Molecular cloning\, mass spectrometry\, site directed mutagenesis\, in-vitro transcription. \nDuties include: \n\nInterprets assay results\nSummarizes findings\nAssist with manuscript preparation.\nPerforms other work related duties as assigned. The omission of specific duties does not preclude the supervisor from assigning duties that are logically related to the position\n\n\nMinimum Qualifications: \nQualified candidates will hold a PhD in a related discipline. Degree must be conferred by the start date of the position \nAdditional Required Licenses/Certifications/Posting Specific Minimum Qualifications: Preferred Qualifications: \nPh.D in biochemistry\, molecular biology\, immunology or related field preferred. \nStrong experience in Immunology\, Epigenetics\, Cancer biology and animal handling\, in addition to some of the following laboratory techniques: tissue culture\, mouse models\, immunological techniques\, molecular biology\, flow cytometry and cellular biology etc. desired.
URL:https://ces.b2sg.org/event/gwu-12jul18/
LOCATION:George Washington University\, 2121 I St NW\, Washington\, DC\, 20052\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/gwu-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180713
DTEND;VALUE=DATE:20180815
DTSTAMP:20260825T164748
CREATED:20180713T062115Z
LAST-MODIFIED:20180713T062115Z
UID:20424-1531440000-1534291199@ces.b2sg.org
SUMMARY:Bioinformatics Research Scientist - Oncology
DESCRIPTION:Overview: \n\n\nProvides expert bioinformatics support for pediatric oncogenomics research. Collaborates with Oncology investigators to enhance understanding of cancer biology through in-depth computational analysis of genomic datasets obtained from primary cancer samples and experimental models. Applies known methods and/or develops novel computational and statistical methods to help analyze genomic data and associated information\, including gene expression\, SNP chip\, array-CGH\, epigenetic\, microRNA and high-throughput sequencing data. Assists in building necessary software infrastructure and tools to facilitate analysis. Assists in preparing and submitting manuscripts for publication and participates in independent bioinformatics research.\n\n\nMinimum Experience \n\n\n\nPh.D which must include research related to bioinformatics (such as analysis of sequence data\, microarrays\, SNPs\, image data\, proteomics data\, or biological pathways; development of algorithms\, statistical methods\, or scientific software); OR If Ph.D with no bioinformatics research\, then two (2) years of pre-or postdoctoral experience in Computational Biology or Bioinformatics research is required\nExperience with programming languages such as Perl\, C\, or Java required\n\n\n\nMinimum Education \n\n\n\nPh.D. in Bioinformatics\, Computational Biology\, Biochemistry\, Molecular Biology or related field required
URL:https://ces.b2sg.org/event/stjude-13jul18/
LOCATION:St. Jude Children’s Hospital\, 262 Danny Thomas Pl\, Memphis\, TN\, 38105\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/stjude.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180714
DTEND;VALUE=DATE:20180816
DTSTAMP:20260825T164748
CREATED:20180714T100204Z
LAST-MODIFIED:20180714T102410Z
UID:20426-1531526400-1534377599@ces.b2sg.org
SUMMARY:Postdoc Research Fellow
DESCRIPTION:The Postdoc Rsh Fellow\, Epigenetic will function under the supervision of a Senior Scientist and Director of the Division of Genetics and Epigenetics. The laboratory has a long standing research program on epigenetics and DNA methylation in normal human development and in common diseases\, including cancer\, Down syndrome\, Alzheimer’s disease and other neurodegenerative disorders\, and autoimmune diseases. Areas of current emphasis include mechanistic studies on genetic-epigenetic interactions that occur in cis and in trans\, using both human samples and mouse models\, and the use of epigenomic mapping as a ‘post-GWAS’ method to identify genes and DNA variants that underlie disease susceptibility. We are also studying epigenetically-acting anti-cancer drugs\, seeking to understand how these agents affect tumor cells and stromal and immune system cells in the tumor microenvironment. Opportunities for post-doctoral training in our group therefore encompass the areas of genome and epigenome analysis using whole genome and targeted approaches in human samples and informative mouse models\, the development of useful bioinformatic methods\, and pre-clinical studies of epigenetically-acting anti-cancer therapies and their effects on the tumor microenvironment in tumor-prone mouse models.\n\n\n\nResponsibilities\n\n\n\n1. Design and perform whole genome and epigenome analyses in human samples and appropriate mouse models\, for understanding mechanisms of disease susceptibility. 2. Develop and apply useful bioinformatic approaches to genomic and epigenomic data for testing mechanistic hypotheses. 3. Present results in internal and external research forums. 4. Participate in grant and manuscript writing\, as appropriate. 5. May design and conduct animal studies using murine models of cancer and Down syndrome. 6. May design and conduct immunological profiling studies in mouse models of Down syndrome and cancer.\n\n\n\nQualifications\n\n\n\nEducation\, Knowledge\, Skills and Abilities Required: 1. Hold a Ph.D. or M.D. Degree from an accredited medical school or graduate level institution. 2. Minimum publication or in preparation of two articles as first author in high quality peer-reviewed scientific journals. Education\, Knowledge\, Skills and Abilities Preferred: 1. Preferred methodologies include genomics/epigenomics\, bioinformatics\, and/or molecular analyses of cells and tissues in mouse models of human disease. 
URL:https://ces.b2sg.org/event/hmh-14jul18/
LOCATION:Hackensack University Medical Center\, 30 Prospect Ave\, Hackensack\, NJ\, 07601\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2018/05/hackensack-hackensackmeridianhealthlogo@2x.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180715
DTEND;VALUE=DATE:20180817
DTSTAMP:20260825T164748
CREATED:20180715T132805Z
LAST-MODIFIED:20180715T132805Z
UID:20429-1531612800-1534463999@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:The Arthanari Lab is seeking for a highly motivated postdoctoral candidate with expertise in transcriptional biology. Our laboratory works at the interface of structural biology\, drug discovery and mechanistic biology\, focusing on transcription factors and there interactions with co-activators and mediators (e.g. Nature. 201625;530(7591):485-9 ; Nature 2008. 452 (7187): 604-9) .Research efforts will be focused on the intersection of cancer biology/genetics and immune-oncology.\n\n\n\nQualifications\n\n\n\nThe candidate is expected to have a comprehensive understanding of signaling pathways\, epigenetics and transcription regulation. Experience in technical skills including cell culture\, somatic genetic analysis (e.g.\, CRISPr\, si\, sh RNA knockdown and rescue)\, protein biochemistry\, assay design and development and biological applications to advance discovery are preferred. The individual should be independent and passionate about science and have an established record of creativity\, ability to work in teams and strong publication record in peer-reviewed scientific journals.
URL:https://ces.b2sg.org/event/dfci-15jul18/
LOCATION:Dana-Farber Cancer Institute\, 450 Brookline Avenue\, Boston\, MA\, 02215\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/11/Dana-Farber.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180716
DTEND;VALUE=DATE:20180818
DTSTAMP:20260825T164748
CREATED:20180716T063818Z
LAST-MODIFIED:20180716T063818Z
UID:20431-1531699200-1534550399@ces.b2sg.org
SUMMARY:Research Fellow
DESCRIPTION:How to Apply\nA cover letter is required for consideration for this position and should be attached as the first page of your resume. The cover letter should address your specific interest in the position and outline skills and experience that directly relate to this position. \nJob Summary\nThe research in my laboratory is focused on understanding the molecular events important in pancreatic cancer development. A postdoctoral or research specialist position is now open for projects aimed at understanding pancreatic cancer biology. Research will be performed utilizing a variety of in vitro and in vivo approaches. \nResponsibilities*\nThe applicant is required to function in an independent fashion and be responsible of his/her own research project. In particular\, he/she will be expected to be able to design experiments\, initially under the PI’s guidance\, conduct experiments\, process and analyze data\, and potentially develop new and/or revise research methodologies. In addition\, the candidate will be expected to present his/her own work both at lab meetings as well as scientific conferences and to critically analyze literature relevant to the research. The successful candidate will be expected to be proficient at scientific writing\, and be able to prepare research papers. While funding is currently available for the position\, the candidate will be strongly encouraged to apply for his/her own funding\, under the PI’s guidance. \nAdditional work related tasks\, similar to but not specifically outlined above\, may be needed in position and while study continues to progress. \nRequired Qualifications*\nA doctoral degree and familiarity with basic laboratory techniques in molecular biology field is required for this position. Previous experience in the field of bioinformatics\, epigenetics\, and in vivo mouse models is a plus\, but not required. Excellent verbal and written communication skills are required. \nDesired Qualifications*\n\nThe candidate will be expected to be familiar with bioinformatics\, basic molecular and cell biology techniques\, and in vivo mouse model studies.\nAdditional expertise in epigenetics is a plus.
URL:https://ces.b2sg.org/event/mi-16jul18/
LOCATION:University of Michigan\, 500 S State St\, Ann Arbor\, MI\, 48109\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/05/uni-michigan.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180719
DTEND;VALUE=DATE:20180821
DTSTAMP:20260825T164748
CREATED:20180719T021548Z
LAST-MODIFIED:20180719T021548Z
UID:20433-1531958400-1534809599@ces.b2sg.org
SUMMARY:Post-Doctoral Research Fellow
DESCRIPTION:A postdoctoral position in the laboratory of Dr. Gavin Ha and the Computational Biology Program is available immediately. We are seeking a highly motivated individual who is interested in studying cancer and understanding the genetic and epigenetic basis driving cancer progression. Candidates who are excited about large/complex ‘omics’ data analysis and methods development for cancer research are encouraged to apply. The position has a duration of at least one year with a competitive salary and great benefits. \n\nThe Ha lab is establishing a research program that uses new DNA sequencing technologies to study cancer genomes. The lab is also focused on research involving liquid biopsies\, such as cell-free DNA\, and developing new computational approaches to leverage these data for genome discovery and cancer burden monitoring. The research interests/projects in the Ha lab include: \n\nAnalysis of cancer genomes to understand tumor progression/evolution\, metastatic disease\, non-coding genome alterations\, copy number alterations\, genome rearrangements and 3D structure\, mutational signatures\nDevelopment of novel computational algorithms for long-range (linked-reads or long-reads) whole genome sequencing of tumors\nAnalysis of linked-read whole genome sequencing data to uncover novel alterations driving metastatic prostate cancer\nAnalysis of cell-free DNA in plasma samples from patients under treatment\nDevelopment and analysis of sensitive approaches to detect tumor-derived DNA in cell-free DNA from patient blood plasma\nThe lab will work with collaborators to validate results using functional experiments\nFor examples of recent studies\, see PMID:29909985\, PMID:29109393\, PMID:25060187\n(please use the apply button below)\n\n\nCandidates with strong interest and/or expertise in any of these research areas are highly encouraged to apply \n\nCancer genomics\, liquid biopsies\, tumor evolution/heterogeneity\nApplication of statistical modeling\, algorithm design\, artificial intelligence to study cancer and genetics\nAnalysis of large\, complex genome\, epigenome\, or transcriptome data\n\n\nQualifications:\nApplicants must have a PhD in one of these disciplines: Computational biology\, bioinformatics\, computer science\, data science\, statistics\, computer/electrical engineering\, physics\, or other related fields \nApplicants should have some of the following skills and experience: \n\nWork well in team environments; strong communication/organization skills; detail-oriented\nStrong programming experience (R\, Python\, Matlab\, Java\, C/C++\, Perl or other languages for research)\nExperience with high performance computing environments and cloud computing environments is a plus\nExperience with analyzing sequencing data is considered a strong asset\nApplicants must have a demonstrated publication track record.\nA background in cancer biology (esp in prostate or breast cancer) is considered a strong asset.\n\n\nTo apply\, please submit your application with the following: \n\na several paragraph statement of research interests\nCV\nnames and email addresses of three references\ntwo representative publications or preprints (if available)
URL:https://ces.b2sg.org/event/hutch-18jul18/
LOCATION:Fred Hutchinson Cancer Research Center
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2016/07/fred_hutch.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180720
DTEND;VALUE=DATE:20180822
DTSTAMP:20260825T164748
CREATED:20180720T033943Z
LAST-MODIFIED:20180720T033943Z
UID:20435-1532044800-1534895999@ces.b2sg.org
SUMMARY:Post-doctoral Fellow | Molecular Biology
DESCRIPTION:About City of Hope \nCity of Hope\, an innovative biomedical research\, treatment and educational institution with over 5\,000 employees\, is dedicated to the prevention and cure of cancer and other life-threatening diseases and guided by a compassionate\, patient-centered philosophy. \nFounded in 1913 and headquartered in Duarte\, California\, City of Hope is a remarkable non-profit institution\, where compassion and advanced care go hand-in-hand with excellence in clinical and scientific research. City of Hope is a National Cancer Institute designated Comprehensive Cancer Center and a founding member of the National Comprehensive Cancer Network\, an alliance of the nation’s 20 leading cancer centers that develops and institutes standards of care for cancer treatment. \nRequisition number 14254 \nPosition Summary and Key Responsibilities:\nPostdoctoral Research Fellow\, Dr. David Chen Laboratory – Department of Systems Biology\, Beckman Research Institute Dr. David Chen’s laboratory in Systems Biology is focused on the epigenetic mechanisms underlying the therapeutic resistance in cancers. This laboratory is skilled in high-throughput CRISPR genetic screens for de novo therapeutic target discovery. They also utilize next-generation sequencing (NGS) for epigenomic and transcriptomic analyses (ChIPseq\, ATACseq\, RNAseq\, etc.)\, and the patient-derived xenograft (PDX) models for in vivo therapeutic efficacy assessments. In addition\, Dr. Chen’s laboratory is involved in cutting-edge technology development including high-density CRISPR protein scan\, and precision epigenome editing.Dr. Chen received his postdoctoral training from Dr. Scott Armstrong in Harvard Medical School. His laboratory in City of Hope currently consists 3 postdocs\, 1 computational biologist\, and 1 technician. The lab is well funded by a 5-year institutional start-up\, an NIH K99/R00 Award\, and an ASH Scholar Award. An additional NIH R01 Award (scored top 3%) is expected to start in 2019. \nQualifications:\nPhD in cell or molecular biology\, genuine enthusiasm for science\, willingness to think beyond established concepts and to try and learn new experimental and analysis tools. The lab takes a team science approach\, so being a nice person and enjoyable to work with is important as well. \nYour application should include in one single PDF :\nCV\, brief motivation statement\, coordinates of three references \nExperience:\nMammalian cell culture\, cell biology (required); Cancer/leukemia-related studies (preferred); Molecular biology\, cloning\, biochemistry (preferred); Animal model studies (preferred); High-throughput sequencing and computational analysis (preferred) 
URL:https://ces.b2sg.org/event/hope-19jul18/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180722
DTEND;VALUE=DATE:20180728
DTSTAMP:20260825T164748
CREATED:20180502T093150Z
LAST-MODIFIED:20180507T143523Z
UID:19965-1532217600-1532735999@ces.b2sg.org
SUMMARY:Chromatin Encounters: Shaping Genome Architecture and Function
DESCRIPTION:The 2018 Gordon Conference on Chromatin Structure and Function will bring together leading experts and newcomers to the field\, to present and discuss their newest research on chromatin\, its complex interactions\, and its regulatory power in shaping genome architecture and function. Technologies to visualize and map chromatin at all levels are proceeding at a rapid pace. The meeting will highlight how chromatin structures\, ranging from the nucleosome – the “building block” of chromatin – up to the dynamic three-dimensional spatial organization of the chromosome\, are assembled\, maintained\, and altered\, and how this ultimately controls genome functions. \nInterconnected questions at the frontier of the field will be addressed – how does the nucleosome interact with other nuclear factors\, how is chromatin assembled\, disassembled\, and maintained in a dynamic state\, what is the molecular basis for the crosstalk between epigenetic modifications and metabolism\, and how does dysfunction of any of these processes result in disease. \nPresentations will encompass a wide variety of innovative technical approaches – from Angstrom level description of chromatin components at all organizational levels to the visualization of micron-scale structures by light microscopy\, and the mapping of chromatin states genome-wide at unprecedented resolution. There will be a focus on new methods to determine chromatin dynamics and the relationships between chromatin structure and function\, and on adapting these to the level of single molecules and single cells. \nApplications for this meeting must be submitted by June 24\, 2018. Please apply early\, as some meetings become oversubscribed (full) before this deadline. If the meeting is oversubscribed\, it will be stated here. Note: Applications for oversubscribed meetings will only be considered by the conference chair if more seats become available due to cancellations. \nDiversity funding: \nFinancial assistance is available for qualified applicants through the GRC Carl Storm Underrepresented Minority Fellowship Program. This program provides a grant to underrepresented minority graduate students\, postdocs\, faculty and scientists to help fund their attendance at their first GRC meeting.  Learn more.
URL:https://ces.b2sg.org/event/grc-22jul18/
LOCATION:Grand Summit Hotel at Sunday River\, 97 Summit Road\, Newry\, ME\, United States
CATEGORIES:Meetings
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2015/12/GRC.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180722
DTEND;VALUE=DATE:20180824
DTSTAMP:20260825T164748
CREATED:20180722T155207Z
LAST-MODIFIED:20180722T155207Z
UID:20437-1532217600-1535068799@ces.b2sg.org
SUMMARY:Postdoctoral Fellow
DESCRIPTION:Postdoctoral fellow positions are available immediately at a leading group in the field of prostate cancer research.  The successful applicant will investigate steroid hormone action\, transcriptional control\, and cell signaling in development and tumorigenesis.  Specifically\, the applicants will develop and use novel and advanced biological approaches\, and genetically-engineered mouse models to uncover gene-expression and genomic and epigenetic alterations in cancer initiating cells in order to understand mechanisms underlying tumor initiation\, progression\, and metastasis. \nWe provide a fruitful research and training environment and competitive salary and fringe benefit.  Applicants should submit their curriculum vitae and the names of three references.  See Zijie Sun lab:  http://www.cityofhope.org/people/sun-zijie. \nMinimum Education and Skills Required for Consideration: \nCandidates should have a recent Ph.D. or M.D/Ph.D. degree in Cancer Biology\, Molecular Biology\, Genetics\, Biochemistry\, Cell Biology\, or a related field. Candidates should be highly self-motivated\, strong working ethic and desire to learn\, and a proven track record of productivity.  Previous experience with mouse models of human diseases\, cancer biology\, and cellular and molecular biology is highly desired.
URL:https://ces.b2sg.org/event/hope-22jul18/
LOCATION:City of Hope\, 1500 East Duarte Road\, Duarte\, 91010\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/02/City-of-hope.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180723
DTEND;VALUE=DATE:20180825
DTSTAMP:20260825T164748
CREATED:20180723T041111Z
LAST-MODIFIED:20180723T041227Z
UID:20440-1532304000-1535155199@ces.b2sg.org
SUMMARY:Post Doctoral Associate
DESCRIPTION:A postdoctoral position is available in the laboratory of Dr. Merav Socolovsky in the Department of Cancer Biology at the University of Massachusetts Medical School. We investigate the process of mammalian blood cell differentiation\, with a focus on epigenetics and the cell cycle. Please visit the Socolovsky Lab Website ( http://labs.umassmed.edu/socolovskylab/) for details on available research areas.\n\n\n\n\nQualifications\n\n\n\nApplicants should have a Ph.D. in Cell\, Developmental or Molecular Biology\, be creative and highly motivated.\n\n\n\n\nAdditional Information\n\n\n\n\n\nPlease send a brief statement of your scientific work and interests\, a CV and the name and email address of three references\, to Merav.socolovsky@umassmed.edu\n\n\n\n\n\n(Please do not apply via the UMMS Career Site)
URL:https://ces.b2sg.org/event/umass-22jul18/
LOCATION:UMass Medical School\,  55 N Lake Ave\, Worcester\, MA\, 01655\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2017/10/umass.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180724
DTEND;VALUE=DATE:20180826
DTSTAMP:20260825T164748
CREATED:20180724T180050Z
LAST-MODIFIED:20180724T180404Z
UID:20445-1532390400-1535241599@ces.b2sg.org
SUMMARY:Associate Scientist | Epigenetics
DESCRIPTION:We are seeking a highly motivated\, positive and engaged team player to join our Epigenetic Discovery group. The successful candidate will work on drug discovery projects focused on Epigenetic and Transcriptional targets. Specifically\, the candidate will be expected to design\, develop and execute experiments that include new target validation\, identification of biomarkers\, elucidation of mechanism of action\, executing existing cell based assays\, and evaluating regular lists of chemical matter to support ongoing SAR efforts. Experience with chromatin IP (ChIP) is highly desired. In addition\, the candidate will assist in creating stable cell lines\, and developing and optimizing new cell based assays to support drug discovery efforts. \nResponsibilities will include\, but are not limited to\, the following \n\nIndependently design\, plan and execute scientific experiments\nAnalyze and interpret scientific data\, troubleshoot and suggest new directions\nConduct routine assays to confirm hits from primary screens and support ongoing SAR efforts\nDevelop\, trouble shoot and optimize new cell based biomarker and functional assays\nAccurately maintain written reports and organize data\nPresent projects in team\, department and project review meetings\nIndependently review current literature pertaining to oncology\, epigenetics\, transcriptional regulation and related assays\n\nExperience/Skills/Knowledge Required \n\nMaster’s degree in a scientific discipline with at least 6 years work experience\, or Bachelor’s degree with at least 8 years work experience.\nIn-depth knowledge of cancer biology and epigenetics\nFamiliarity with drug discovery process for epigenetic and transcriptional targets in oncology\nExperience with target ID / validation efforts\nExperience in executing and developing cell-based assays\, and small molecule hit confirmation efforts\nExperience in molecular and cell biology techniques including cell culture\, transfection and transduction techniques (overexpression\, RNAi\, CRISPR)\, stable cell line generation/validation\, viability assays\, functional/phenotypic assays such as viability and apoptosis in 2D and 3D settings\, real time PCR\, protein assays such as immunoblotting and/or protein simple\, RNA assays including qPCR and/or Nanostring\, microscopy. Experience in ChIP assays is desired\nHighly motivated\, positive\, capable of multitasking\, attention to detail\, and innovative\nExcellent time management and organizational skills\, strong written and oral communication skills\, ability to think creatively and solve problems are essential
URL:https://ces.b2sg.org/event/celgene-24jul18/
LOCATION:Celgene San Francisco\, 1500 Owens St\, CA\, 94158\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/celgene-1-e1503843775806.png
END:VEVENT
END:VCALENDAR